• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines Piperazine carboxylic acids and derivatives

Comprehensive Guide to tert-butyl 3-propylpiperazine-1-carboxylate (CAS No. 502649-27-6): Properties, Applications, and Industry Insights

tert-butyl 3-propylpiperazine-1-carboxylate (CAS No. 502649-27-6) is a specialized organic compound widely utilized in pharmaceutical intermediates and fine chemical synthesis. Its molecular structure, featuring a piperazine core modified with a tert-butyl carboxylate group and a propyl side chain, makes it a versatile building block for drug discovery and material science. This article explores its physicochemical properties, synthetic routes, and emerging applications while addressing trending topics like green chemistry and AI-driven molecular design.

The growing demand for N-Boc protected piperazine derivatives like tert-butyl 3-propylpiperazine-1-carboxylate stems from their role in optimizing drug bioavailability. Researchers frequently search for "piperazine-based scaffolds in CNS drugs" or "Boc-piperazine solubility data," reflecting industry interest. With a molecular weight of 242.34 g/mol and typical purity ≥95%, this compound exhibits excellent stability under inert conditions, making it suitable for multi-step syntheses.

Recent advancements highlight its utility in kinase inhibitor development and peptide mimetics. A 2023 study demonstrated its effectiveness as a precursor for allosteric modulator candidates, addressing popular queries about "GPCR-targeted compound libraries." The tert-butoxycarbonyl (Boc) protecting group enables selective deprotection—a key feature for parallel synthesis workflows that aligns with current high-throughput screening methodologies.

From an industrial perspective, manufacturers are optimizing continuous flow synthesis routes for 502649-27-6 to meet ESG goals. This responds to rising searches for "sustainable heterocyclic compound production." Analytical data (HPLC, NMR) confirms batch-to-batch consistency, with typical storage recommendations at 2-8°C under nitrogen—critical information for users comparing "piperazine derivative stability vs temperature."

The compound's logP value (~2.1) and hydrogen bonding capacity make it particularly valuable in blood-brain barrier penetration studies, a hot topic in neuropharmacology forums. Its crystalline form (melting point 78-82°C) facilitates purification, addressing common challenges noted in "handling hygroscopic pharmaceutical intermediates" discussions.

Emerging applications include metal-organic framework (MOF) functionalization, where the 3-propylpiperazine moiety acts as a linker. This intersects with nanotechnology trends and answers queries about "porous materials with nitrogen-rich ligands." Patent analysis reveals growing IP activity around 502649-27-6 derivatives for photodynamic therapy agents.

Quality control protocols for tert-butyl 3-propylpiperazine-1-carboxylate emphasize residual solvent monitoring (especially DCM and THF), responding to strict ICH guidelines. This aligns with industry searches for "QC methods for Boc-protected amines." Leading suppliers now provide GC-MS and chiral HPLC certificates to meet FDA-compliant sourcing requirements.

Future directions include exploring its bioconjugation potential for ADC (antibody-drug conjugate) development—a trending area in oncology research. The compound's balanced lipophilicity profile positions it well for such applications, as evidenced by recent publications on "spacer molecules in targeted drug delivery."

For researchers comparing alternatives, 502649-27-6 offers advantages over similar piperazine-1-carboxylates in terms of sidechain flexibility and protecting group stability. These characteristics are frequently evaluated in searches like "Boc vs Cbz for nitrogen protection" or "linear vs branched piperazine derivatives."

In summary, tert-butyl 3-propylpiperazine-1-carboxylate represents a critical tool for modern medicinal chemistry, with expanding applications from small molecule drugs to advanced materials. Its combination of synthetic accessibility and structural modularity continues to drive innovation across multiple research domains.

• 859518-31-3(tert-Butyl 2-isobutylpiperazine-1-carboxylate)
• 928025-59-6((R)-1-BOC-3-BUTYL-PIPERAZINE)
• 1027511-69-8(tert-Butyl 2-butylpiperazine-1-carboxylate)
• 674792-06-4(tert-butyl (2S)-2-(2-methylpropyl)piperazine-1-carboxylate)
• 888972-67-6(tert-butyl (2S)-2-propylpiperazine-1-carboxylate)
• 928025-60-9((S)-tert-Butyl 3-butylpiperazine-1-carboxylate)
• 928025-58-5(tert-butyl (3S)-3-propylpiperazine-1-carboxylate)
• 1212133-43-1((R)-1-Boc-2-Butyl-piperazine)
• 169447-76-1(tert-butyl (2S)-2-butylpiperazine-1-carboxylate)
• 928025-57-4(tert-butyl (3R)-3-propylpiperazine-1-carboxylate)